News
Rio Tinto, Hancock to Jointly Invest $1.6 Billion in Hope Downs 2 Project The world's second-largest miner by market value said the project will include two new pits capable of producing a combined 31 ...
Stocks rallied Tuesday after U.S. President Donald Trump announced a ceasefire in the Israel-Iran conflict, although the ...
On Monday, major U.S. indices ended the day in the green with the Dow Jones Industrial Average rising 0.9% to 42,581.78, and the S&P 500 gaining nearly 1% to 6,025.17.
The Danish pharmaceutical said it was ending the partnership because Hims is selling and promoting a cheaper copycat of its ...
The Financial Times covers major global stories, including Novo Nordisk ending its partnership with Hims & Hers over drug ...
The Danish maker of obesity drugs abruptly ended a Wegovy distribution deal with the telehealth firm, citing allegations ...
4h
Asianet Newsable on MSNHims & Hers CEO Hits Back At Novo Nordisk After Abrupt End Of Collaboration, Alleges Wegovy-Maker Is ‘Misleading The Public’CEO Andrew Dudum on Monday expressed disappointment at Novo Nordisk’s (NVO) decision to cancel its collaboration with the ...
Novo Nordisk said Monday it will end its collaboration with Hims & Hers that offered the weight loss medication Wegovy for patients who have a prescription for the medication but no insurance coverage ...
Stocks rally and oil tumbles as Wall Street hopes for a limited retaliation after US strikes on Iran
The calming in the oil market came as several analysts said Iran would likely refrain from closing the waterway. Iran itself ...
Hims & Hers Health Inc.'s stock booked record losses Monday after pharmaceutical giant Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ending a collaboration with the telehealth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results